LIANY

LIANBIO SP/ADR by LianBio (LIANY)

About LIANBIO SP/ADR by LianBio (LIANY)

LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.

Details

Daily high
$0.06
Daily low
$0.05
Price at open
$0.05
52 Week High
$0.44
52 Week Low
$0.03
Market cap
4.9M
Dividend yield
0.00%
Volume
162,643
Avg. volume
656,594
P/E ratio
--

LIANBIO SP/ADR by LianBio News

Details

Daily high
$0.06
Daily low
$0.05
Price at open
$0.05
52 Week High
$0.44
52 Week Low
$0.03
Market cap
4.9M
Dividend yield
0.00%
Volume
162,643
Avg. volume
656,594
P/E ratio
--